Skip to main content
SpringerLink
Log in
Book cover

Genes, Oncogenes, and Hormones pp 193–211Cite as

Anti-p185HER2 monoclonal antibodies: Biological properties and potential for immunotherapy

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 61))

Abstract

It is by now clear that the pathogenesis of human cancer involves the aberrant functioning of the products of oncogenes. In breast and other cancers, the HER2 protooncogene appears to play an important role in the development and progression of these diseases. As such, it represents a potential focus for therapeutic intervention.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shih, C., Padhy, L.C., Murray, M., Weinberg, R.A. (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261–263.

    Article  PubMed  CAS  Google Scholar 

  2. Schecter, A.L., Stern, D.F., Vaidyanatha, L., Decker, S.J., Drebin, J.A., Greene, M.I., Weinberg, R.A. (1984) The neu gene: An erbB-related gene encoding a 185,000-Mr tumor antigen. Nature 312:513–516.

    Article  Google Scholar 

  3. Bargmann, C.I., Hung, M.C., Weinberg, R.A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649–657.

    Article  PubMed  CAS  Google Scholar 

  4. Bargmann, C.I., Weinberg, R.A. (1988) Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad. Sci. U.S.A. 85:5394–5398.

    Article  PubMed  CAS  Google Scholar 

  5. Semba, K., Kamata, N., Toyoshima, K., Yamamoto, T. (1985) A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1 epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 82:6497–6501.

    Article  PubMed  CAS  Google Scholar 

  6. King, C.R., Kraus, M.H., Aaronson, S.A. (1985) Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974–976.

    Article  PubMed  CAS  Google Scholar 

  7. Coussens, L., Yang-Feng, T.L., Liao, Y.C., Chen, E., Gray, A., McGrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., Francke, U., Levinson, A., Ullrich, A. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139.

    Article  PubMed  CAS  Google Scholar 

  8. Fukushige, S.I., Matsubara, K.I., Yoshida, M., Sasaki, M., Suzuki, T., Semba, K., Toyoshima, K., and Yamamoto, T. (1986) Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol. 6:955–958.

    PubMed  CAS  Google Scholar 

  9. Kraus, M.H., Popescu, N.C., Amsbaugh, S.C., King, C.R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6:605–610.

    PubMed  CAS  Google Scholar 

  10. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., McGuire, W.L. (1987) Human breast cancer: Correlation of relapse and survival with amplification of HER2/new oncogene. Science 235:177–182.

    Article  PubMed  CAS  Google Scholar 

  11. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J, Ullrich, A, Press, M. (1989) Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.

    Article  PubMed  CAS  Google Scholar 

  12. Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T., Yokota, J., Yoshida, T., Sakamoto, H., Terada, M., Sugimura, T. (1989). Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res. 49:3104–3108.

    PubMed  CAS  Google Scholar 

  13. Paik, S., Hazan, R., Fisher, E.R., Sass, R.E., Fisher, B., Redmond, C., Schlessinger, J., Lippman, M.E., King, C.R. (1990) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erbB-2 protein overexpression in primary breast cancer. J. Clin. Oncol. 8:103–112.

    PubMed  CAS  Google Scholar 

  14. Paterson, M.C., Dietrich, K.D., Danyluk, J., Paterson, A.H.G., Lees, A.W., Jamil, N., Hanson, J., Jenkins, H., Krause, B.E., McBlain, W.A., Slamon, D.J., Fourney, R.M. (1991) Correlation between c-erbB-2 amplification and risk of recurrent disease in nodenegative breast cancer. Cancer Res. 51:556–567.

    PubMed  CAS  Google Scholar 

  15. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J.T., Dodge, R., Clarke-Pearson, D.L., Marks, P., McKenzie, S., Yin, S., Bast, R.C., (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:4087–4091.

    PubMed  CAS  Google Scholar 

  16. Borst, M.P., Baker, V.V., Dixon, D., Hatch, K.D., Shingleton, H.M., Miller, D.M. (1990) Oncogene alterations in endometrial carcinoma. Gynecol. Oncol. 38:364–366.

    Article  PubMed  CAS  Google Scholar 

  17. Berchuck, A., Rodriguez, G., Kinney, R.B., Soper, J.T., Dodge, R.K., Clarke-Pearson, D.L., Bast, R.C. (1991) Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am. J, Obstet. Gynecol. 164:15–21.

    CAS  Google Scholar 

  18. Yonemura, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazakil, I., Endou, Y., Tanaka, M., Sasaki, T. (1991) Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res. 51:1034–1038.

    PubMed  CAS  Google Scholar 

  19. Kern, J.A., Schwartz, D.A., Nordberg, J.E., Weiner, D.B., Greene, M.I., Torney, L., Robinson, R.A. (1990) p185new expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 50:5184–5191.

    PubMed  CAS  Google Scholar 

  20. Riviere, A., Becker, J., Loning, T. (1991) Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer 67:2142–2149.

    Article  PubMed  CAS  Google Scholar 

  21. Schneider, P.M., Hung, M.C., Chiocca, S.M., Manning, J., Zhao, X., Fang, K., Roth, J.A. (1989) Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res. 49:4968–4971.

    PubMed  CAS  Google Scholar 

  22. Tal, M., Wetzler, M., Josefberg, Z., Deutch, A., Gutman, M., Assaf, D., Kris, R., Shiloh, Y., Givol, D., Schlessinger, J. (1988) Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res. 48:1517–1520.

    PubMed  CAS  Google Scholar 

  23. D’Emilia, J., Bulovas, K., D’Ercole, K., Wolf, B., Steele, G., Summerhayes, I.C. (1989) Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 4:1233–1239.

    PubMed  Google Scholar 

  24. Zhau, H.E., Zhang, X., von Eschenbach, A.C., Scorsone, K., Babaian, R.J., Ro, J.Y., Hung, M.C. (1990) Amplification and expression of the c-erbB-2/neu proto-oncogene in human bladder cancer. Mol. Carcinogen 3:254–257.

    Article  CAS  Google Scholar 

  25. Wright, C., Mellon, K., Neal, D.E., Johnston, P., Corbett, I.P., Home, C.H.W. (1990) Expression of c-erbB-2 protein product in bladder cancer. Br. J. Cancer 62:764–765.

    Article  PubMed  CAS  Google Scholar 

  26. Moriyama, M., Akiyama, T., Yamamoto, T., Kawamoto, T., Kato, T., Sato, K., Watanuki, T., Hikage, T., Katsuta, N., Mori, S. (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J. Urol. 145:423–427.

    PubMed  CAS  Google Scholar 

  27. Aasland, R., Lillehaug, J.R., Male, R., Josendal, O., Varhaug, J.E., Kleppe, K. (1988) Expression of oncogenes in thyroid tumours: Coexpression of c-erbB2/neu and c-erbB. Br. J. Cancer 57:358–363.

    Article  PubMed  CAS  Google Scholar 

  28. Imamura, N., Miyazawa, T., Mtasiwa, D., Kuramoto, A. (1990) Co-expression of N-ras p21 and C-erbB-2 (neu) oncogene products by common ALL antigen-positive aggressive diffuse lymphoma. Lancet 336:825–826.

    Article  PubMed  CAS  Google Scholar 

  29. Di Fiore, P.P., Pierce, J.H., Kraus, M.H., Segatto, O., King, C.R., Aaronson, S.A. (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178–182.

    Article  PubMed  Google Scholar 

  30. Hudziak, R.M., Schlessinger, J., Ullrich, A. (1987) Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 84:7159–7163.

    Article  PubMed  CAS  Google Scholar 

  31. Muller, W.J., Sln, E., Pattengale, P.K., Wallace, R., Leder, P. (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115.

    Article  PubMed  CAS  Google Scholar 

  32. Suda, Y., Aizawa, S., Furuta, Y., Yagi, T., Ikawa, Y., Saitoh, K., Yamada, Y., Toyoshima, K., Yamamoto, T. (1990) Induction of a varicty of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659 → Glu659). EMBO J. 9:181–190.

    PubMed  CAS  Google Scholar 

  33. Shepard, H.M., Lewis, G.D. (1988) Resistance of tumor cells to tumor necrosis factor. J. Clin. Immunol. 8:1–9.

    Article  Google Scholar 

  34. Hudziak, R.M., Lewis, G.D., Shalaby, M.R., Eessalu, T.E., Aggarwal, B.B., Ullrich, A., Shepard, H.M. (1988) Amplified expression of the HER2/ErbB2 oncogene induces resistance to tumor necrosis factor-α in NIH3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 85:5102–5106.

    Article  PubMed  CAS  Google Scholar 

  35. Lichtenstein, A., Berenson, J., Gera, J.F., Waldburger, K., Martiniz-Maza, D., Berek, J.S. (1990) Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: Correlation with expression of HER2/neu oncogenes. Cancer Res. 50:7364–7370.

    PubMed  CAS  Google Scholar 

  36. Lonardo, F., Di Marco., E, King, C.R., Pierce, J.H., Segatto, O., Aaronson, S.A., Di Fiore, P.P. (1991) The normal erbB-2 product is an atypical receptor-lkie tyrosine kinase with constitutive activity in the absence of ligand. New Biol. 2:99–1003.

    Google Scholar 

  37. Press, M.F., Cordon-Cardo, C., Slamon, D.J. (1990) Expression of the HER-2/neu protooncogene in normal human adult and fetal tissues. Oncogene 5:953–962.

    PubMed  CAS  Google Scholar 

  38. Fendly, B.M., Winget, M., Hudziak, R.M., Lipari, M.T., Napier, M.A., Ullrich, A. (1990) Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor of HER2/new gene product. Cancer Res. 50:1550–1558.

    PubMed  CAS  Google Scholar 

  39. Hudziak, R.M., Lewis, G.D., Winget, M., Fendly, B.M., Shepard, H.M., Ullrich, A. (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell Biol. 9:1165–1172.

    PubMed  CAS  Google Scholar 

  40. Shepard, H.M., Lewis, G.D., Sarup, J.C., Fendly, B.M., Maneval, D., Mordenti, J., Figari, I., Kotts, C.E., Palladino, M.A., Ullrich, A., Slamon, D. (1991) Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic. J. Clin. Immunol. 11:117–127.

    Article  PubMed  CAS  Google Scholar 

  41. Sarup, J.C., Johnson, R.M., King, K.L., Fendly, B.M., Lipari, M.T., Napier, M.A., Ullrich, A., Shepard, H.M. (1991) Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. Growth Regul. 1:72–82.

    PubMed  CAS  Google Scholar 

  42. Drebin, J.A., Link, V.C., Stern, D.F., Weinberg, R.A., Greene, M.I. (1985) Downmodulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41:695–706.

    Article  Google Scholar 

  43. Myers, J.N., Drebin, J.A., Wada, T., Greene M.I. (1991) Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185. In: Methods in Enzymology, Vol. 198 Academic Press, San Diego, pp. 277–290.

    Google Scholar 

  44. McKenzie, S.J., Marks, P.J., Lam, T., Morgan, J., Panicali, D.L., Trimpe, K.L., Carney, W.P. (1989) Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene 4:543–548.

    PubMed  CAS  Google Scholar 

  45. van Leeuwen, van de Vijver, M.J., Lomans, J., van Deemter L., Jenster, G., Akiyama, T., Yamamoto, T., Nusse, R. (1990) Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies. Oncogene 5:497–503.

    PubMed  Google Scholar 

  46. Yarden, Y. (1990). Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Proc. Natl. Acad. Sci. U.S.A. 87:2569–2573.

    Article  PubMed  CAS  Google Scholar 

  47. Taglibue, E., Centis, F., Campiglio, M., Mastroianni, A., Martignone, S., Pellegrini, R., Casalini, P., Lanzi, C., Menard, S., Colnaghi, M.I. (1991) Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/neu gene amplification. Int. J. Cancer 47:933–937.

    Article  Google Scholar 

  48. Dilman, R.O. (1989-1990) Present status and future of monoclonal antibodies. Biotech Ther. 1:87–107.

    Google Scholar 

  49. Carter, P., Presta, L., Gorman, C.M., Ridgway, J.B.B., Henner, D., Wong, W.L.T., Rowland, A.M., Kotts, C., Carver, M.C., Shepard, H.M. (1991) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A., in press.

    Google Scholar 

  50. Friguet, B., Chaffotte, A.F., Djavadi-Ohaniance, L., Goldberg, M.E. (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzymelinked immunosorbent assay. J. Immunol. Methods 77:305–319.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. John W. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Stagg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gail D. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Maneval
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dennis J. Slamon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Howard Jaffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Michael Shepard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, D.C., USA

    Robert B. Dickson  & Marc E. Lippman  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Park, J.W. et al. (1991). Anti-p185HER2 monoclonal antibodies: Biological properties and potential for immunotherapy. In: Dickson, R.B., Lippman, M.E. (eds) Genes, Oncogenes, and Hormones. Cancer Treatment and Research, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3500-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3500-3_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6552-5

  • Online ISBN: 978-1-4615-3500-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation